Innova Biosciences Develops Technology to Increase Sensitivity of Diagnostic Tests
28 Feb 2013

Innova Biosciences has recently launched a technology called Thunder-Link® which will facilitate the development of diagnostic tests. The innovative technology has been designed to allow non-specialists to engineer oligonucleotide conjugates with ease. Such biomolecule complexes are increasingly used in high-sensitivity diagnostic kits, and are designed to overcome limited sensitivity and linear range often encountered with traditional antibody-enzyme conjugates. Prior to Thunder-Link® such biomolecules were difficult and expensive to develop and required specialist knowledge.

Commenting on the launch Nick Gee, CEO, 'All of Innova's products in one way or other are geared towards generating conjugates more easily and quickly and improving assay performance. The launch of the Thunder-Link® range of oligo conjugation products firmly places Innova as a key reagent supplier to the diagnostic industry and will assist in bringing high performance diagnostic kits to market.'

Request Info


Company website

Innova Biosciences Ltd.